These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 21497044)
21. Oral anticoagulant therapy in patients with atrial fibrillation. Pengo V Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467 [TBL] [Abstract][Full Text] [Related]
22. [Anticoagulants in non-valvular atrial fibrillation. A clinical dilemma in practice]. Carlsäter J; Kristjansson G; Nilsson G Lakartidningen; 1994 Aug; 91(35):3053-6. PubMed ID: 7983939 [No Abstract] [Full Text] [Related]
23. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?]. MMW Fortschr Med; 2006 Sep; 148(38):14. PubMed ID: 17036954 [No Abstract] [Full Text] [Related]
24. Warfarin therapy for elderly persons with atrial fibrillation. Ackermann RJ Am Fam Physician; 1998 Jul; 58(1):45-6, 48-9. PubMed ID: 9672429 [No Abstract] [Full Text] [Related]
25. Anticoagulation of atrial fibrillation in older people: a clinical practice observational study. Abdelhafiz AH; Wheeldon NM J Am Geriatr Soc; 2006 Jan; 54(1):176-7. PubMed ID: 16420226 [No Abstract] [Full Text] [Related]
26. Anticoagulation for atrial fibrillation patients with CHADS score of 1. Lane DA; Lip GY J Cardiovasc Electrophysiol; 2010 May; 21(5):508-10. PubMed ID: 20082649 [No Abstract] [Full Text] [Related]
27. Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse. Wyse DG Circulation; 2007 May; 115(21):2684-6. PubMed ID: 17533193 [No Abstract] [Full Text] [Related]
28. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164 [TBL] [Abstract][Full Text] [Related]
30. [Von Willebrand disease: a common and unrecognized bleeding disorder]. Boehlen F; Robert-Ebadi H; de Moerloose P Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733 [TBL] [Abstract][Full Text] [Related]
31. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
32. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210 [TBL] [Abstract][Full Text] [Related]
33. Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis. Watson T; Shantsila E; Blann A; Lip GY Thromb Haemost; 2010 Aug; 104(2):327-34. PubMed ID: 20508899 [TBL] [Abstract][Full Text] [Related]
34. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation. Morgan SV Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835 [No Abstract] [Full Text] [Related]
35. Digitalis: a dangerous drug in atrial fibrillation? Testa L; Bhindi R; Banning AP Heart; 2008 Dec; 94(12):1654; author reply 1654-5. PubMed ID: 19011140 [No Abstract] [Full Text] [Related]
36. Predicting bleeding risk in anticoagulated patients with atrial fibrillation. Rosenstein R; DiMaggio E J Am Coll Cardiol; 2011 Sep; 58(13):1399; author reply 1398-9. PubMed ID: 21920274 [No Abstract] [Full Text] [Related]
37. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
38. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
39. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
40. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses. Rothlin ME Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]